http://www.cff.org/aboutCFFoundation/NewsEvents/Vertex-Submits-VX-770-Application-to-FDA.cfm
They start the second part of the Phase 2 trial on Vertex's VX-809 drug this month. VX- 809 is the other drug Tyler was on during his trial (he needs the combination of the VX-770 and VX-809). Vertex is also beginning research on a new drug, Vertex 661, which is only for people with two Delta F 508s. This drug could be even more promising for Tyler!
For all of those who give to the Cystic Fibrosis Foundation, you're making a difference!
"/>"/>
"/>"/>
"/>"/>"/>




Whoop! I'm so so excited about this!
ReplyDelete